Clinical Trials Browser

Phase 2 × Antibodies × Clear all

Squamous Cell Carcinoma of Head and Neck

NCT02458638 2021-06-04

A Study of Atezolizumab in Advanced Solid Tumors

Phase 2 Completed

474 enrolled 14 charts

Tumor-Agnostic

Neoplasms

NCT00145613 2009-02-13

Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies

Phase 2 Completed

25 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hemoglobinuria, Paroxysmal, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT00143559 2009-01-29

Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies

Phase 2 Completed

17 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hemoglobinuria, Paroxysmal, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Clinical Trials

PembroRad

A Study of Atezolizumab in Advanced Solid Tumors

Haploidentical Stem Cell Transplant for Treatment Refractory Hematological Malignancies

Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies